Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 60
- Medical
‘Incredibly Bullish’: How Canada’s Biggest Cannabis Players Are Conquering Europe (Part 1)
As Canada works out how to deal with calls from its southern neighbour to become the 51st US state, it is expanding its own invasion on a very different front.
- Adult-Use
Illinois’ Cannabis Market Hits Record $2bn in Sales
Illinois’ cannabis industry hit $2 billion in total sales in 2024, generating $490 million in tax revenue, marking another year of growth since recreational cannabis was legalized in 2020.
- Press releases
Curaleaf Clinic Maintains Highest CQC Rating, Reinforcing Leadership in Medical Cannabis Care
Curaleaf Clinic remains the highest rated medical cannabis clinic by the Care Quality Commission (CQC) having retained its ‘Outstanding’ rating in the ‘Well-led’ category and a ‘Good’ overall, affirming its commitment to excellence in patient care.
- Events
European Cannabis Week Returns in 2025, Uniting London and Berlin in Landmark Industry Event
After a six-year hiatus, European Cannabis Week (ECW) announces its return, scheduled for June 19-25, 2025. This reimagined cross-border initiative will connect two of Europe’s cannabis capitals — Berlin & London — bringing together industry leaders, policymakers, and innovators across multiple premier events.
- Markets & Stocks
Jazz Pharma Wards Off Epidiolex Patent Challenges, Hellenic Fights for Survival in Court, & OCT Rebrands to Octavian
Earlier this week, Jazz dismissed a patent claim against Apotex, Canada’s largest generic drug producer, as it reached a settlement with the company, the details of which were undisclosed.
- Cultivation
Trump’s DEA Revolving Door: 4th Administrator in as Many Months Rings Alarm Bells for Cannabis Industry
The fourth head of the Drug Enforcement Administration (DEA) in as many months has been given the green light by President Donald Trump, painting an even more worrying picture for the future of cannabis in the US.
- Uncategorized
Republican Senators Introduce Bill to Block Cannabis 280E Tax Relief Even if Cannabis Is Rescheduled
As the cannabis rescheduling project hangs in the balance, two Republican senators are attempting to ensure that one of its core benefits would be made redundant, even if rescheduling is successful.
- Opinion
The UK Risks Missing Out on the Next $1 Billion Cannabinoid Opportunity
A groundbreaking achievement is flying under the radar. Epidiolex, the first FDA approved cannabis-derived drug developed by GW Pharmaceuticals, is on track to surpass $1 billion in annual revenue—a feat that puts it in the league of blockbuster drugs like Humira and Lipitor.
- Press releases
Newgrove and Wellford Go Fully Digital with Script Assist
Script Assist is excited to announce new partnerships with Newgrove Pharmacy and Wellford Medical Clinics, marking a significant shift in how medical cannabis is prescribed and dispensed in the UK.
- Uncategorized
Arizona Attempts to Force Funding of Medical Cannabis Research Through Sales Taxes
Arizona lawmakers are attempting to force the state’s Department of Health Services (DHS) to put millions of dollars towards medical cannabis research.
- Uncategorized
Hawaii House Shelves Recreational Cannabis Bill in Stunning Reversal
Less than 48 hours after Hawaii lawmakers appeared poised to legalize recreational cannabis, the state’s House of Representatives unexpectedly slammed the brakes, shelving the measure until at least 2026.
- Medical
Spain Finally Takes Step Toward Medical Cannabis, But ‘Feeble’ Proposals Disappointing for Patients
Spain’s long-awaited medical cannabis program has finally taken a step forward as a draft of a Royal Decree has been sent to the European Union for approval.
